Latest Partnerships And Deals News

Nine Entertainment has locked in exclusive free-to-air and streaming rights for NRL and NRLW matches from 2028 to 2034, reinforcing its dominance in Australian sports broadcasting and promising continued audience growth.

Helia Group has renewed its exclusive Lenders Mortgage Insurance contract with ING Bank Australia for four years from July 2026, preserving a significant revenue stream representing about 20% of its FY25 premiums.

Chimeric Therapeutics has appointed Hawkesbury Partners to lead a strategic review aimed at exploring options to enhance shareholder value, reflecting concerns that its market cap undervalues its clinical assets and infrastructure.

The GPT Wholesale Shopping Centre Fund is set to deepen its retail property exposure with a $1.2 billion acquisition of interests in two major super-regional shopping centres, Sunshine Plaza and Macarthur Square. This move leverages recent capital raises and underlines GPT's strategy to scale through partnerships.

Quantum Graphite Limited has secured a binding Ore Supply Agreement with Sunlands Pure Group, consolidating downstream graphite processing and refining under a 20-year exclusive partnership. The deal sets ambitious production targets and pricing safeguards, underpinning Quantum's strategy to scale purified graphite supply for battery anodes and thermal storage markets.

Scentre Group's first quarter update reveals robust retail sales growth and strong leasing metrics, alongside significant capital management moves including bond redemption and a major joint venture stake sale.

Vectus Biosystems reports a narrowed half-year loss as it advances clinical drug VB0004 and nears a key asset sale to XORTX Therapeutics.

FlexiRoam Limited reveals a strong financial turnaround with AI-powered innovations driving profitability and margin expansion in the first half of FY26. The company’s strategic partnerships and zero-integration platform position it well in the fast-growing eSIM market.

Proteomics International has secured a US patent for its PromarkerEso blood test, a pioneering diagnostic tool for early detection of esophageal adenocarcinoma, marking a critical step toward commercialisation in the world’s largest healthcare market.

DroneShield has landed a $49.6 million contract to supply handheld counterdrone systems to a European military customer, with deliveries and payments expected to complete by Q1 2026.

Mineral Resources Limited and POSCO Holdings have agreed to form a $1.2 billion joint venture for their lithium assets, marking a significant step in global lithium supply partnerships. The deal will strengthen MinRes’ balance sheet and deepen ties between Australia and Korea in critical minerals.

Neurizon Therapeutics has been granted a key Australian patent for its lead drug candidate NUZ-001, extending protection for treatments targeting ALS, Alzheimer's, and other neurodegenerative diseases through 2041. This milestone complements earlier US patent grants and sets the stage for upcoming clinical trials.